Over 11.4 million Nigerians battle diabetes as a 300% surge in drug costs forces patients to ration medicine or use herbs. Experts warn of rising amputations and 40,000 yearly deaths, calling for a state of emergency. Read the full investigation.
Nigeria faces a rising diabetes crisis, with up to 8 million adults affected. Poor diets and ultra-processed foods drive NCDs, now the leading cause of death. Urgent policy action on SSB taxes and food labeling is needed.
Nigeria's Health Minister Prof. Ali Pate joins CSOs urging Senate to replace fixed ₦10/litre SSB tax with percentage-based levy to curb rising diabetes, obesity rates and fund healthcare.
The West African Institute of Public Health advocates technology integration to address Nigeria's growing non-communicable disease burden. Learn how digital solutions can transform healthcare.
NSCDC FCT Command partners with Abuja Metropolitan Lions Club for workplace diabetes screening. Free health checks, drugs boost personnel wellness for safer capital.
LUTH experts warn diabetes could affect 40% of Nigerians within 30 years. They urge workplace support, prevention strategies, and sugar tax implementation to combat rising cases.
Delta State and Sanofi introduce a new digital platform to enhance diabetes monitoring and patient education. Over 200 healthcare professionals trained. Read more on this health initiative.
Federal Government begins nationwide diabetes screening using locally manufactured glucose monitors. Program aims to test 5 million Nigerians across 774 LGAs with free diagnostic kits distribution.
The Diabetes Association of Nigeria stresses early detection to prevent diabetes complications. Learn risk factors and the importance of regular health checkups for wellbeing.
As Nigeria marks World Diabetes Day, millions remain undiagnosed. Discover how local innovation and awareness can combat this silent epidemic. Take action for your health today!
Cross River State announces groundbreaking plan to prioritize diabetes management in 2026 budget, signaling major healthcare transformation for residents.
Major pharmaceutical battle intensifies as Novo Nordisk challenges Pfizer in high-stakes acquisition race for obesity treatment specialist Metsera, reshaping the weight-loss drug market.